NewGenIvf Group Ltd当前公司基本面数据相对稳定,增长潜力较大。当前估值低估,在医疗服务供应商行业排名74/78位。机构持股占比低,近一月多位分析师给出公司评级为。最高目标价75.00。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。
NewGenIvf Group Ltd评分
相关信息
行业排名
74 / 78
全市场排名
521 / 4562
所属行业
医疗服务供应商
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
75.000
目标均价
+5036.99%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
NewGenIvf Group Ltd亮点
亮点风险
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
公司代码NIVF
公司NewGenIvf Group Ltd
CEOWing Fung (Siu)
网址https://newgenivf.com/
常见问题
NewGenIvf Group Ltd(NIVF)的当前股价是多少?
NewGenIvf Group Ltd(NIVF)的当前股价是 0.797。
NewGenIvf Group Ltd的股票代码是什么?
NewGenIvf Group Ltd的股票代码是NIVF。
NewGenIvf Group Ltd股票的52周最高点是多少?
NewGenIvf Group Ltd股票的52周最高点是2450.000。
NewGenIvf Group Ltd股票的52周最低点是多少?
NewGenIvf Group Ltd股票的52周最低点是0.781。
NewGenIvf Group Ltd的市值是多少?
NewGenIvf Group Ltd的市值是343.36K。
NewGenIvf Group Ltd的净利润是多少?
NewGenIvf Group Ltd的净利润为-524.64K。
现在NewGenIvf Group Ltd(NIVF)的股票是买入、持有还是卖出?
根据分析师评级,NewGenIvf Group Ltd(NIVF)的总体评级为--,目标价格为75.000。
NewGenIvf Group Ltd(NIVF)股票的每股收益(EPS TTM)是多少
NewGenIvf Group Ltd(NIVF)股票的每股收益(EPS TTM)是576.582。